NANOTHERAPEUTICS, INC.

Company Information

Company Name
NANOTHERAPEUTICS, INC.
Address
13859 Progress Blvd.
ALACHUA, FL, -
Phone
1 386-462-9663
URL
n/a
DUNS
n/a
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,809,993.00
10
SBIR Phase II
$2,371,112.00
4
STTR Phase I
$99,705.00
1
Chart code to be here

Award List

  1. Development of A Synthetic Typhoid Fever Vaccine as A Substitution of Vi Vaccine

    Amount: $595,945.00

    DESCRIPTION (provided by applicant) Typhoid fever is a major cause of morbidity worldwide with an estimated incidence of 16 to 33 million infections and 500,000 to 600,000 deaths annually. It is caus ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. N/A

    Amount: $98,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  3. N/A

    Amount: $98,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  4. N/A

    Amount: $70,000.00

    N/A

    SBIR Phase I 2000 National Aeronautics and Space Administration
  5. Slow Release Coatings for Inhaled Dynorphins

    Amount: $99,705.00

    DESCRIPTION (provided by applicant): Opiate abuse remains a major problem in the United States. NIDA stressed the need for new treatment concepts, such as anti-craving compounds the dev ...

    STTR Phase I 2001 Department of Health and Human Services
  6. Novel Dry-Powder Coatings for Low-G Inhalation Therapy

    Amount: $538,071.00

    Currently, dry-powder inhalers (DPI) are used to deliver various drugs to the lungs for localized or systemic delivery. Although current inhaled formulations are adequate for pulmonary drug therapy un ...

    SBIR Phase II 2001 National Aeronautics and Space Administration
  7. Novel Dry-Powder Coatings for Low-G Inhalation Therapy

    Amount: $0.00

    Currently, dry-powder inhalers (DPI) are used to deliver various drugs to the lungs for localized or systemic delivery. Although current inhaled formulations are adequate for pulmonary drug therapy un ...

    SBIR Phase I 2001 National Aeronautics and Space Administration
  8. Antimicrobial Bone Graft Substitute

    Amount: $69,938.00

    In this Phase I SBIR project, Nanotherapeutics proposes to utilize its proprietary particle delivery systems to develop an injectable bone paste formulation incorporating an anti-microbial (PHMB) as a ...

    SBIR Phase I 2005 ArmyDepartment of Defense
  9. Oral Therapy using Anti-Oxidants for Alzheimer's Disease

    Amount: $100,816.00

    DESCRIPTION (provided by applicant): Nanotherapeutics proposes to evaluate oral taurine therapy for Alzheimer's disease (AD). AD, the most common form of dementia among older people, affects over 4 mi ...

    SBIR Phase I 2004 Department of Health and Human Services
  10. ORAL BUPRENORPHINE NANOPARTICLE FORMULATION

    Amount: $98,838.00

    N/A

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government